SLE (SYSTEMIC LUPUS)
Clinical trials for SLE (SYSTEMIC LUPUS) explained in plain language.
Never miss a new study
Get alerted when new SLE (SYSTEMIC LUPUS) trials appear
Sign up with your email to follow new studies for SLE (SYSTEMIC LUPUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
CAR-T therapy takes on lupus: could this be a Game-Changer for kidney damage?
Disease control Not yet recruitingThis study tests a new treatment called CRC01, made from a patient's own immune cells, for people with severe lupus that has damaged their kidneys. About 39 adults with lupus nephritis will receive a single infusion of these cells after a short course of chemotherapy. The goal is…
Matched conditions: SLE (SYSTEMIC LUPUS)
Phase: PHASE1, PHASE2 • Sponsor: Curocell Inc. • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
New drug ISH0613 gets first human test – healthy volunteers wanted
Knowledge-focused Not yet recruitingThis early-stage study tests a new drug, ISH0613, in 26 healthy adults to see how safe it is and how the body processes it. Participants get one IV dose of either the drug or a placebo and are closely monitored for side effects. This research is a first step before testing the dr…
Matched conditions: SLE (SYSTEMIC LUPUS)
Phase: PHASE1 • Sponsor: SUNHO（China）BioPharmaceutical CO., Ltd. • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:49 UTC